5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 18.76▲ | 18.06▲ | 17.84▲ | 17.86▲ | 16.92▲ |
MA10 | 18.18▲ | 17.82▲ | 18.15▲ | 17.85▲ | 17.33▲ |
MA20 | 18.34▲ | 18.51▲ | 18.63▲ | 16.83▲ | 17.13▲ |
MA50 | 18.28▲ | 17.77▲ | 17.49▲ | 17.43▲ | N/A |
MA100 | 17.46▲ | 16.78▲ | 16.92▲ | 17.06▲ | N/A |
MA200 | 16.99▲ | 17.74▲ | 17.52▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.097▲ | -0.037▼ | -0.151▼ | 0.198▲ | N/A |
RSI | 57.264▲ | 57.704▲ | 57.709▲ | 60.499▲ | 59.508▲ |
STOCH | 97.668▲ | 41.373 | 26.647 | 49.256 | 25.918 |
WILL %R | 0.000▲ | -29.954 | -29.954 | -28.305 | -68.716 |
CCI | 98.278 | 60.565 | 31.980 | 106.870▲ | 23.006 |
Wednesday, April 30, 2025 09:36 AM
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
|
Tuesday, April 29, 2025 11:17 PM
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging ...
|
Tuesday, April 29, 2025 01:52 AM
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agentMELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 18.795 | 18.85 | 18.63 | 18.85 | 29,231 |
01/05/25 | 17.86 | 18.15 | 17.55 | 17.94 | 15,504 |
30/04/25 | 17.48 | 17.48 | 17.138 | 17.40 | 10,044 |
29/04/25 | 17.45 | 17.63 | 17.45 | 17.52 | 13,452 |
28/04/25 | 17.21 | 17.90 | 17.1196 | 17.57 | 72,435 |
25/04/25 | 19.23 | 19.47 | 18.7001 | 18.80 | 30,101 |
24/04/25 | 18.48 | 19.9278 | 18.47 | 19.22 | 43,330 |
23/04/25 | 17.49 | 18.9499 | 17.49 | 18.30 | 49,728 |
22/04/25 | 16.8721 | 16.9299 | 16.31 | 16.67 | 20,390 |
21/04/25 | 16.91 | 16.98 | 16.1404 | 16.21 | 17,591 |
|
|
||||
|
|
||||
|
|